Skip to content

This site is intended for healthcare professionals

The Royal Pharmaceutical Society's official journal
PJ logo PJ logo
Log in
  • Monthly edition
    • Latest issues
      • January 2026
      • December 2025
      • November 2025
      • October 2025
      • September 2025
      • August 2025
      • July 2025
      • June 2025
      • May 2025
      • April 2025
      • March 2025
      • February 2025
  • News
    • Type
      • Latest news
      • Features & analysis
      • Opinion
      • Letters
      • Podcasts
      • RPS news
      • Job listings
      • Tributes & obituaries
      • Events
    • Theme
      • Royal college proposals
      • Antimicrobial stewardship
      • Digital pharmacy
      • COVID-19
      • Health inequalities
      • Genomic medicine
      • Green pharmacy
      • Medicines safety
      • Medicines shortages
      • Palliative and end-of-life care
      • Polypharmacy
      • OPERA 2025
      • Women to Watch 2024
    • Sector
      • Community
      • General practice
      • Hospital
      • Industry
    • Location
      • England
      • Scotland
      • Wales
    • Condition
      • Addiction
      • Cancer
      • Cardiovascular diseases
      • Dermatology
      • Diabetes
      • Elderly care
      • Gastrointestinal system diseases
      • Infectious diseases
      • Mental health
      • Minor ailments
      • Musculoskeletal conditions
      • Neurological conditions
      • Paediatrics and neonatal
      • Pain: acute
      • Pain: chronic
      • Renal diseases
      • Respiratory tract diseases
      • Sexual health
      • Women's health
  • CPD & Learning
    • Career stage
      • Pharmacy students
      • Foundation trainees
      • Early years pharmacists
      • Advanced practice
    • Theme
      • Professional skills
      • Prescribing
      • Antimicrobial resistance and stewardship
      • Revalidation
      • Palliative and end-of-life care
    • Condition
      • Allergy
      • Cancer
      • Cardiovascular diseases
      • Dermatology
      • Diabetes
      • Eye
      • Gastrointestinal conditions
      • Infectious diseases
      • Mental health
      • Minor ailments
      • Musculoskeletal conditions
      • Neurological conditions
      • Oral health
      • Paediatrics and neonatal
      • Pain management
      • Palliative care
      • Renal health
      • Respiratory tract diseases
      • Sexual health
      • Urgent and emergency care
      • Women's health
    • Career development
      • Changing sectors
      • Finding a preregistration placement
      • Getting a new job
      • Progressing your career
      • Returning to practice
      • Surviving your first year
  • Research
    • Publications
      • Journal of Pharmacy and Pharmacology
      • International Journal of Pharmacy Practice
      • Journal of Pharmaceutical Health Services Research
      • Pharmaceutics and Pharmacology
    • Researcher awards
      • OPERA 2025
      • OPERA 2024
      • OPERA 2023
  • PJ Jobs
    • Jobseekers
    • Recruiters
Log in Subscribe
The official journal of The Royal Pharmaceutical Society
    • All Monthly edition
    • Latest issues
      • January 2026
      • December 2025
      • November 2025
      • October 2025
      • September 2025
      • August 2025
      • July 2025
      • June 2025
      • May 2025
      • April 2025
      • March 2025
      • February 2025
    • All News
    • Type
      • Latest news
      • Features & analysis
      • Opinion
      • Letters
      • Podcasts
      • RPS news
      • Job listings
      • Tributes & obituaries
      • Events
    • Theme
      • Royal college proposals
      • Antimicrobial stewardship
      • Digital pharmacy
      • COVID-19
      • Health inequalities
      • Genomic medicine
      • Green pharmacy
      • Medicines safety
      • Medicines shortages
      • Palliative and end-of-life care
      • Polypharmacy
      • OPERA 2025
      • Women to Watch 2024
    • Sector
      • Community
      • General practice
      • Hospital
      • Industry
    • Location
      • England
      • Scotland
      • Wales
    • Condition
      • Addiction
      • Cancer
      • Cardiovascular diseases
      • Dermatology
      • Diabetes
      • Elderly care
      • Gastrointestinal system diseases
      • Infectious diseases
      • Mental health
      • Minor ailments
      • Musculoskeletal conditions
      • Neurological conditions
      • Paediatrics and neonatal
      • Pain: acute
      • Pain: chronic
      • Renal diseases
      • Respiratory tract diseases
      • Sexual health
      • Women's health
    • All CPD & Learning
    • Career stage
      • Pharmacy students
      • Foundation trainees
      • Early years pharmacists
      • Advanced practice
    • Theme
      • Professional skills
      • Prescribing
      • Antimicrobial resistance and stewardship
      • Revalidation
      • Palliative and end-of-life care
    • Condition
      • Allergy
      • Cancer
      • Cardiovascular diseases
      • Dermatology
      • Diabetes
      • Eye
      • Gastrointestinal conditions
      • Infectious diseases
      • Mental health
      • Minor ailments
      • Musculoskeletal conditions
      • Neurological conditions
      • Oral health
      • Paediatrics and neonatal
      • Pain management
      • Palliative care
      • Renal health
      • Respiratory tract diseases
      • Sexual health
      • Urgent and emergency care
      • Women's health
    • Career development
      • Changing sectors
      • Finding a preregistration placement
      • Getting a new job
      • Progressing your career
      • Returning to practice
      • Surviving your first year
    • All Research
    • Publications
      • Journal of Pharmacy and Pharmacology
      • International Journal of Pharmacy Practice
      • Journal of Pharmaceutical Health Services Research
      • Pharmaceutics and Pharmacology
    • Researcher awards
      • OPERA 2025
      • OPERA 2024
      • OPERA 2023
    • All PJ Jobs
    • Jobseekers
    • Recruiters
Subscribe
Access provided by 
  1. Home
  2. Publications

Pharmacy closures dropped by more than half in 2021, show NHS data

Faded closed sign in old chemist shop window in Norfolk

Analysis by The Pharmaceutical Journal found net closures of 93 community pharmacies in England in 2021, compared with 202 closures the previous year.…

Arthur Francis Bramham (1931–2022)

On 2 January 2022, Arthur Francis Bramham, aged 90 years, of Nottingham. Mr Bramham registered with the Society in 1954.…

Hear it here first: a year of the PJ Pod

collage of hand throwing mortarboard in air, amazon pharmacy logo, international symbol of access, covid-19 and antibodies

During our first full year of The PJ Pod, we explored a range of topics including mental health in the face of COVID-19, hidden disabilities in pharmacy and a closer look at the diversity of the MPharm degree.…

Read all about it: the top 10 features of 2021

collage of cartoon vaccine, lateral flow test, asthma inhaler with black mist coming out, cartoon woman's face with tablets as spots, NICE building, pharmacy cross with help wanted stamped on it

Our array of topical, detailed analyses makes for an impressive set of features to look back on from 2021.…

Government orders 4.3 million further doses of COVID-19 antivirals

Molnupiravir

The 1.8 million doses of molnupiravir and 2.5 million doses of PF-07321332/ritonavir are in addition to the courses that were announced in October 2021.…

Boots and PDAU agree final pay deal for Boots pharmacists

Boots signage

The Pharmacists' Defence Association Union has decided not to proceed with a ballot on possible industrial action.…

Molnupiravir less effective at preventing death from COVID-19 than previously thought, study update shows

Manufacturers maintain the latest trial results still support the efficacy of the drug for mild-to-moderate COVID-19 in adults at high risk for disease progression.…

AstraZeneca says its antibody drug prevents COVID-19 infection for six months in high-risk patients

A syringe is placed on a document with the AstraZeneca logo

Trial results published by manufacturer AstraZeneca show that a one-off dose of Evusheld reduced the risk of developing symptomatic COVID-19 by 83%, compared to placebo.…

Paul Bennett: ‘We’ve got a real opportunity to make a difference’

Paul Bennett, chief executive of the Royal Pharmaceutical Society

Just a few weeks after the Royal Pharmaeutical Society published its declaration of climate and ecological emergency, we caught up with chief executive Paul Bennett to find out what members can expect from this campaign.…

Oriel situational judgement test: what pharmacy students need to know

Arrows on the pavement

The Oriel situational judgement test is designed to determine what action you would take when presented with certain scenarios while working as a preregistration pharmacist. Here is what you need to consider before and during this assessment.…

  1. 1
  2. 2
  3. 3
  4. 4
  5. …
  6. 448
  • PJ logo PJ logo
    • About us
    • A to Z subjects
  • Services

    • Advertising and branded content
    • Subscribe
    • Partnership working
  • Support

    • Article access rules
    • Community guidelines
    • For authors and referees
    • Website FAQs
    • Using the new PJ
    • Logging in as a RPS member
    • Preferences and newsletters
    • How to use the PJ app
    • PJ app FAQs
    • Technical support
  • Publications

    • The Pharmaceutical Journal
    • International Journal of Pharmacy Practice
    • Journal of Pharmacy and Pharmacology
    • Journal of Pharmaceutical Health Services Research
    • Pharmaceutics and Pharmacology
  • Partners

    • Pharmaceutical Press
    • MedicinesComplete
    • Pharmacy Knowledge ONtrack
    • PJ Jobs
  • Contact

    • Contact us
    • Permissions and reprints
  • Follow us

    • Social media and communities hub
    • Twitter logo
    • Facebook logo
    • Linkedin logo
    • Download our app

      Get it from the App Store Get it on Google Play
  • Acceptable use policy
  • Accessibility
  • Cookie policy
  • Copyright
  • Privacy policy
  • Subscription T&Cs
  • T&Cs
© 2026 Royal Pharmaceutical Society